An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A - Concepedia

Concepedia

Publication | Open Access

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

DOI Full Paper Access

124

Citations

38

References

2014

Year

Shahram Attarian, Jean‐Michel Vallat, Laurent Magy, Benoît Funalot, Pierre‐Marie Gonnaud, Arnaud Lacour, Yann Péréon, O. Dubourg, Jean Pouget, Joëlle Micallef,

Orphanet Journal of Rare Diseases

References

	Year	Citations

Page 1